Health Connection Get connected to a healthier life
These studies established an excellent safety and tolerability profile, with no serious adverse events attributed to the compound
"The significant reduction in risk of composite endpoint of heart attack, stroke, or death seen in the SOUL trial in adults with type 2 diabetes highlights the cardiovascular impact of oral semaglutide in adult patients with cardiometabolic conditions such as type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease," said Dr John B Buse, Distinguished Professor of Medicine, Director of UNC Diabetes Care Center, Steering Committee Co-Chair of the SOUL trial
Separating doses throughout the day sacrifices this synergistic effect
Our guide details mechanism, half-life, dosing, and side effects to help you choose the best option for your goals
And those are the minor side effects